Keyphrases
Randomized Trial
100%
Digoxin
100%
Patients with Chronic Heart Failure
100%
Congestive Heart Failure
80%
Angiotensin-converting Enzyme Inhibitor (ACEi)
50%
Inotropic Agents
20%
Clinical Practice
10%
Increased Mortality
10%
Heart Blood
10%
Placebo
10%
Improved Survival
10%
Left Ventricular Function
10%
Randomized Placebo-controlled Trial
10%
Left Ventricular Ejection Fraction
10%
Exercise Capacity
10%
National Heart
10%
Heart-lung
10%
Sinus Rhythm
10%
Double-blind Randomized Trial
10%
Inhibitor Therapy
10%
Multidrug
10%
Systolic Left Ventricular Dysfunction
10%
Digitalis Glycosides
10%
Maladies
10%
Radiance
10%
Nursing and Health Professions
Congestive Heart Failure
100%
Digoxin
100%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Inotropic Agent
20%
Patient with Congestive Heart Failure
20%
Placebo
20%
Clinical Practice
10%
National Health Organization
10%
Sinus Rhythm
10%
Heart Left Ventricle Ejection Fraction
10%
Left Ventricular Systolic Dysfunction
10%
Digitalis Glycoside
10%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Digoxin
100%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Placebo
20%
Inotropic Agent
20%
Left Ventricular Systolic Dysfunction
10%
Digitalis Glycoside
10%
Neuroscience
Digoxin
100%
ACE Inhibitor
50%
Inotropic Agent
20%
Placebo
20%
Digitalis Glycoside
10%